Best Read Articles on FDA Approvals in 2021


The approval of the generic version of smoking-cessation drug Chantix (varenicline) garnered a lot of attention as did the OKs of Besremi (ropeginterferon alfa-2b-njft), a treatment for polycythemia vera, and Trudhesa (dihydroergotamine mesylate), a nasal spray for acute treatment of migraines.

FDA Approves Generic of Chantix, Pfizer's Smoking Cessation Drug

This is the first approval of generic version of Chantix, and it comes just weeks after a recall of the brand-name drug.

Read more

FDA Approves Treatment for Rare Blood Disease

Besremi is the first interferon approved to treat a disease that causes the overproduction of red blood cells.

Read more

FDA Approves Therapy for Age-Related Blurry Vision

Vuity, developed by Allergan, is a once-daily eye drop to treat presbyopia.

Read more

FDA Clears Novel Nasal Spray for Migraine

The therapy, to be launched in October, is delivered quickly to the bloodstream by targeting the upper nasal space.

Read more

FDA Approves Novel Therapy for Macular Degeneration

Genentech’s Susvimo is a refillable implant that delivers medication continuously for up to six months.

Read more

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.